Symbol lookup for: "SGN"

8 Results

Symbol Company Name Type Stock Price Market Cap
SGNSigning Day Sports, Inc.Stock1.003.62M
WSE:SGNSygnity S.A.Stock100.002.25B
HOSE:SGNSaigon Ground Services JSCStock63,900.002,162.92B
TSXV:SGNScorpio Gold CorporationStock0.2044.27M
BOM:531812SGN Telecoms LimitedStock0.7067.88M
TSX:SGNLSignal Gold Inc.Stock0.0921.68M
SGNLFSignal Gold Inc.Stock0.0615.23M
SGNFXSparrow Growth Fund No-Load ClassMutual Fund48.7123.55M

News search for "SGN"

SIGNING DAY SPORTS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Signing Day Sports, Inc. - SGN

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger o...

Related symbols: SGN
12 days ago - Business Wire

Eyenovia & SGN Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye Disease

The U.S. addressable market for Dry Eye Disease is valued at over $3 billion by independent sources The U.S. addressable market for Dry Eye Disease is valued at over $3 billion by independent sources

Related symbols: EYEN
11 months ago - GlobeNewsWire

LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd2/LAVA-1223)

Milestone triggered by clinical progress in Phase 1 study, initiated in Q4 2023 Milestone triggered by clinical progress in Phase 1 study, initiated in Q4 2023

Related symbols: LVTX
1 year ago - GlobeNewsWire

Pieris Pharmaceuticals Announces $5 Million Milestone from Seagen for Initiation of Phase 1 Trial of CD228 x 4-1BB Bispecific Molecule (Mabcalin SGN-BB228 (PRS-346)

BOSTON, MA / ACCESSWIRE / January 10, 2023 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® tech...

2 years ago - Accesswire